Home LiteratureArticle Details
PMID: 2159532 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells.

Journal of virology ·Vol. 64 ·No. 6 ·1990-06-00 ·Pages 2569-76

Johnson DC, Burke RL, Gregory T

Abstract

Herpes simplex virus type 1 (HSV-1) and HSV-2 plaque production was inhibited by treating cells with soluble forms of HSV-1 glycoprotein D (gD-1t) and HSV-2 glycoprotein D (gD-2t). Both glycoproteins inhibited entry of HSV-1 and HSV-2 without affecting virus adsorption. In contrast, a soluble form of HSV-2 glycoprotein B had no effect on virus entry into cells. Specific binding of gD-1t and gD-2t to cells was saturable, and approximately 4 x 10(5) to 5 x 10(5) molecules bound per cell. Binding of gD-1t was markedly reduced by treating cells with certain proteases but was unaffected when cell surface heparan sulfate glycosaminoglycans were enzymatically removed or when the binding was carried out in the presence of heparin. Together, these results suggest that gD binds to a limited set of cell surface receptors which may be proteins and that these interactions are essential for subsequent virus entry into cells. However, binding of gD to its receptors is not required for the initial adsorption of virus to the cell surface, which involves more numerous sites (probably including heparan sulfate) than those which mediate gD binding.

MeSH Terms
Adsorption Animals Binding, Competitive Cell Line Humans Kinetics Receptors, Virus/metabolism Simplexvirus/physiology Solubility Vero Cells Viral Envelope Proteins/metabolism Viral Plaque Assay Virus Replication
Chemicals
Receptors, Virus Viral Envelope Proteins glycoprotein D, Human herpesvirus 1
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Johnson D C
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Burke R L
Gregory T
References (32)
32 references, click to expand
  1. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.
    J Virol. 1974 Sep;14(3):640-51 PMID: 4369085
  2. INHIBITION OF HERPES VIRUS BY NATURAL AND SYNTHETIC ACID POLYSACCHARIDES.
    Proc Soc Exp Biol Med. 1964 May;116:140-4 PMID: 14200087
  3. Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection.
    J Virol. 1980 May;34(2):512-20 PMID: 6246278
  4. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    J Virol. 1983 Feb;45(2):672-82 PMID: 6187935
  5. Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D.
    Science. 1983 Nov 4;222(4623):524-7 PMID: 6312563
  6. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4 PMID: 6087328
  7. Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion.
    J Virol. 1984 Oct;52(1):238-47 PMID: 6090699
  8. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  9. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
    Science. 1985 Mar 22;227(4693):1490-2 PMID: 2983428
  10. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    J Virol. 1985 Aug;55(2):347-51 PMID: 2410629
  11. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
    J Virol. 1985 Aug;55(2):475-82 PMID: 2991570
  12. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    J Immunol. 1985 Nov;135(5):3151-62 PMID: 2995487
  13. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  14. Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis.
    J Virol. 1986 Nov;60(2):674-82 PMID: 3022001
  15. Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene.
    J Virol. 1987 Feb;61(2):326-35 PMID: 3027364
  16. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin.
    J Virol. 1987 Jul;61(7):2208-16 PMID: 3035221
  17. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    J Virol. 1987 Aug;61(8):2438-47 PMID: 3037106
  18. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5454-8 PMID: 3037552
  19. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
    Cell. 1987 Sep 11;50(6):975-85 PMID: 2441877
  20. Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus.
    J Virol. 1988 Jan;62(1):159-67 PMID: 2824844
  21. Herpes simplex virus glycoprotein treatment of recurrent genital herpes.
    J Infect Dis. 1988 Jan;157(1):156-63 PMID: 2826603
  22. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.
    J Virol. 1988 May;62(5):1486-94 PMID: 2833603
  23. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1.
    J Gen Virol. 1988 Jun;69 ( Pt 6):1137-45 PMID: 2838567
  24. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.
    J Virol. 1988 Aug;62(8):2596-604 PMID: 2839688
  25. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    J Immunol. 1988 Sep 1;141(5):1720-7 PMID: 2842401
  26. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.
    J Virol. 1988 Dec;62(12):4452-64 PMID: 2460635
  27. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.
    J Virol. 1989 Jan;63(1):52-8 PMID: 2535752
  28. Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.
    J Virol. 1989 Feb;63(2):819-27 PMID: 2536105
  29. The major human rhinovirus receptor is ICAM-1.
    Cell. 1989 Mar 10;56(5):839-47 PMID: 2538243
  30. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.
    Cell. 1989 Mar 10;56(5):849-53 PMID: 2538244
  31. Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.
    J Virol. 1990 Jan;64(1):278-86 PMID: 2152816
  32. Non-producer human cells induced by murine sarcoma virus.
    Int J Cancer. 1975 Jan 15;15(1):23-9 PMID: 165148
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1990-06-00
Pages
2569-76
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC249433
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com